$Cassava Sciences (SAVA.US)$ SAVA very undervalued for being...
$Cassava Sciences(SAVA.US$ SAVA very undervalued for being the only safest treatment of AD patients in Phase 3 trials. Making the news for its short squeeze potential
![$Cassava Sciences (SAVA.US)$ SAVA very undervalued for being the only safest treatment of AD patients in Phase 3 trials. Making the news for its short squeeze p...](https://ussnsimg.moomoo.com/sns_client_feed/71846513/20240614/396da2a9d2965bbf17d54040d36a7266.jpg/big?area=100&is_public=true)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment